Tag List


Best Available Treatment Study (BATS) for Multisystem Inflammatory Syndrome in Children (MIS-C)

PIPSQC is pleased to share the following resources on multisystem inflammatory syndrome in children (MIS-C) - which include information on the Best Available Treatment Study (BATS):
- WHO - Multisystem Inflammatory Syndrome in Children and Adolescents temporally related to COVID-19 - Global Collaborative Effort (slides)
- CDC - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 - COCA Webinar (slides)
- Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series

In addition, PIPSQC is pleased to highlight the following pediatric critical care resources:
- Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital
- Improving timely recognition and treatment of sepsis in the pediatric ICU
- Journal of Pediatric Critical Care - Special Supplement on COVID-19
- Just-in-Time Simulation to Guide Workflow Design for Coronavirus Disease 2019 Difficult Airway Management
- Pediatric Readiness in the Emergency Department and Its Association With Patient Outcomes in Critical Care: A Prospective Cohort Study
- SCCM - VIRUS COVID-19 Registry Dashboard

Also of note are the following articles on the impact of COVID-19 on at-risk children:
- Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US
- Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children
- Risks to children and young people during covid-19 pandemic

Last but not least are the recent articles below:
- Boston Children's Hospital to lead nationwide study on COVID-19 in children
- COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features
- Ethnicity and COVID-19 in children with comorbidities
- Inclusion of Children in Clinical Trials of Treatments for Coronavirus Disease 2019 (COVID-19)
- POPCoRN network mobilizes pediatric capacity during pandemic
- WHO - Solidarity Call to Action - to realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data